Dungeons, Dragons & Diagnosing Startup Challenges

Explore the unusual parallel between facilitating team collaboration to solve problems in fast-paced startups and role-playing games.
Something Old, Something New: What is a 505(b)2?

We explore the 505(b)2 pathway for expedited approval of previously-approved active drug ingredients with new formulations.
Three Drug Ideas that Deserve Redemption

We discuss three life science ideas that struggled on the market, but whose potential impact warrant a second look.
Good Ideas Gone Bad: The (Old & New) Worst Drug Launch In History

We discuss how approved drugs can fail on the market through a case examination of Exubera® and Aduhelm®.
Perfecting PCR with Rover Diagnostics

We explore how Rover Diagnostics is arming patients, practitioners, and public health officials with critical information by innovating PCR!
Tailoring Antibodies to Suit Emerging Diseases with Ichor Biologics

We explore how Ichor Biologics is leveraging its next-generation platform to harness and improve on antibody-based therapeutics.
Connecting Through Your Medicine with Emocha Health
We explore how emocha Health is changing how payers, providers, and patients address challenges with medication adherence.
The Pediatric Promise of Curie Dx

We explore how CurieDx is creating easy-to-use, at-home diagnostics to help parents manage some of the most common childhood illnesses.
Transplanting Transparancy into Surgical Costs with Kermit

Today’s Startup Showcase is for an organization on the cutting edge of molecular diagnostics for ovarian cancer and so much more.
Diagnosing Ovarian Cancer, the Silent Killer, with HYPERmelt

Today’s Startup Showcase is for an organization on the cutting edge of molecular diagnostics for ovarian cancer and so much more.